Tag Archives: Prescription Drugs

Health Care: Amazon Alexa “Medicine Tracker” Reminds People To Take And Refill Prescriptions

From a Becker’s Hospital review news release:

Amazon Alexa Medicine TrackerAny customer with an active prescription and an Alexa-enabled device will be able to access the medication management skill on the device, a Giant Eagle spokesperson told CNBC. Rachel Jiang, who leads the Amazon Alexa health and wellness team, said the company began developing the skill after noticing that customers were using the devices to create medication reminders.

Beyond a simple reminder, the skill also offers more information about medication regimens and can be used to order refills. When the skill is installed, Alexa, which was confirmed earlier this year to be HIPAA-compliant, will prompt users to set up a profile and passcode, which must be delivered each time Alexa is asked a question about a medication.

Amazon and Pittsburgh-based supermarket and pharmacy chain Giant Eagle have formed a partnership that will allow Amazon Echo devices to offer Giant Eagle pharmacy patients medication reminders, CNBC reports.

To read more: https://www.beckershospitalreview.com/healthcare-information-technology/amazon-alexa-will-now-remind-giant-eagle-pharmacy-patients-to-take-medication.html?oly_enc_id=9129H5611090H0N

 

 

Podcasts: “Intitute For Clinical And Economic Review” (ICER) Is Helping To Lower Drug Prices (WSJ)

Wall Street Journal PodcastsAn obscure think tank in Boston is getting drug companies to lower their prices – using something called a QALY. WSJ’s Denise Roland explains what a QALY is, and why it’s controversial.

Health Care System: Life-Saving Drug Shortages At U.S. Hospitals Reach “Unfathomable” Levels

From a Becker’s Hospital Review online release:

Massachusetts General Hospital“This is the fourth time in the last two years we’ve had to activate our hospital’s emergency operations plan for a major drug shortage,” Dr. Biddinger told NBC News. “It’s almost unfathomable in modern medicine. I never thought we would get to a point in the U.S. healthcare system where we wouldn’t have essential medicines to be able to treat patients.”

Drug shortages are increasing and lasting longer, according to an FDA report published Oct. 29. Of 163 drugs running low in 2013-17, over 62 percent were due to manufacturing or product quality problems.

Hospitals nationwide are facing shortages of crucial, lifesaving drugs, with 116 drugs currently running low, according to the FDA and cited by NBC News.

Boston-based Massachusetts General Hospital is a prime example, getting as close as two weeks away from canceling a lifesaving cardiac surgery due to a lack of herapin, a blood-thinner, according to Paul Biddinger, MD, chief of the division of emergency preparedness at Massachusetts General Hospital.

To read more: https://www.beckershospitalreview.com/pharmacy/it-s-almost-unfathomable-in-modern-medicine-us-hospitals-running-low-on-lifesaving-drugs.html?oly_enc_id=9129H5611090H0N

Drug Reviews: Top Ten Antiobiotics Used For Patients In Hospital ER’s

From a Becker’s Hospital Review online release:

Ceftriaxone and azithromycin are the top two most commonly administered antibiotics in U.S. emergency rooms for patients who are not admitted to the hospital, according to a study published in the American Journal of Health-System Pharmacy.

American Journal of Health System PharmacyThe top 10 most commonly administered antibiotics in the ER for nonadmitted patients were:

• ceftriaxone: 30.6 percent
• azithromycin: 10.8 percent
• clindamycin: 6.6 percent
• levofloxacin: 5.8 percent
• cephalexin: 5.3 percent
• metronidazole: 4.5 percent
• sulfamethoxazole-trimethoprim: 4.2 percent
• ciprofloxacin: 3.9 percent
• amoxicillin: 3.8 percent
• penicillin: 3.3 percent

The researchers also found that most common emergency room diagnoses were urinary tract infections and cellulitis, and that prescribing practices generally aligned with treatment guidelines for these diagnoses.

To read more: https://www.beckershospitalreview.com/quality/10-most-common-antibiotics-administered-in-the-er.html?oly_enc_id=9129H5611090H0N

Health Care: Greater Use Of “Biosimilars” Could Save System $7 Billion

From a Health Care Finance News online article:

HealthCare Finance NewsBut greater use of biosimilars could create significantly more savings. If biosimilars obtained a 75 percent market share, less than the share of these medicines in many European Union nations, the resulting annual savings for the U.S. healthcare system could be nearly $7 billion, based on Winegarden’s analysis.

Not all drugs are created the same. Take generics and biologics: The former is a chemical-based medicine whose manufacture is easily replicated, while the latter is created using biological processes.

But there’s another key difference between those two classes of drugs, and it pertains to the financial state of the healthcare industry and to U.S. taxpayer dollars. Stated plainly, biosimilars have the opportunity to bring significant savings to state Medicaid programs and consumers with commercial insurance. That gives them a leg up over their chemical-based counterparts.

To read more: https://www.healthcarefinancenews.com/news/expanding-biosimilars-market-holds-potential-significant-savings-state-medicaid-programs?mkt_tok=eyJpIjoiTTJGbU1qTXpOVFpqTm1WbCIsInQiOiJrU3puNU4xNVB2eTBBVkpwQ3FGaWhYdDJwZEV0M1dlcFRBakNpOFZ5YVYyanpSSk9HeVZCQTBHbjY4ZktFXC82cm9JeWE3S2dUWm5HMXByYTVoOVB6SG9FaWRIWnRta2ZzZUNvN1g2WHVneVNtVEFpT1ZlZjEwWk1KbmFaXC9qN3N2In0%3D

Prescription Drugs: BioEthicist Travis Rieder’s Personal Struggle With Opioids (Podcast)

From NPR podcast of Fresh Air with Terry Gross:

FreshAir Terry GrossRieder likens his experiences trying to get off prescription pain meds to a game of hot potato. “The patient is the potato,” he says. “Everybody had a reason to send me to somebody else.”

Eventually Rieder was able to wean himself off the drugs, but not before receiving bad advice and going through intense periods of withdrawal. He shares his insights as both a patient and a bioethicist in a new book, In Pain: A Bioethicist’s Personal Struggle With Opioids.

Press play button above to hear interview.

Travis Reider book In Pain Review

In 2015, Travis Rieder, a medical bioethicist with Johns Hopkins University’s Berman Institute of Bioethics, was involved in a motorcycle accident that crushed his left foot. In the months that followed, he underwent six different surgeries as doctors struggled first to save his foot and then to reconstruct it.

Rieder says that each surgery brought a new wave of pain, sometimes “searing and electrical,” other times “fiery and shocking.” Doctors tried to mitigate the pain by prescribing large doses of opioids, including morphine, fentanyl, Dilaudid, oxycodone and OxyContin. But when it came time to taper off the drugs, Rieder found it nearly impossible to get good advice from any of the clinicians who had treated him.

Read more

https://www.npr.org/sections/health-shots/2019/07/08/738952129/motorcycle-crash-shows-bioethicist-the-dark-side-of-quitting-opioids-alone